Skip to Content
Morningstar

Franklin Biotechnology Discovery Adv FTDZX

Morningstar Medalist Rating
Medalist Rating as of | See Franklin Templeton Investment Hub
  • NAV / 1-Day Return 137.03  /  +1.26 %
  • Total Assets 855.2 Mil
  • Adj. Expense Ratio
    0.820%
  • Expense Ratio 0.820%
  • Distribution Fee Level Below Average
  • Share Class Type Institutional
  • Category Health
  • Investment Style Mid Blend
  • Min. Initial Investment 100,000
  • Status Open
  • TTM Yield —
  • Turnover 24%

USD | NAV as of Apr 23, 2024 | 1-Day Return as of Apr 23, 2024, 10:14 PM GMT+0

Morningstar’s Analysis FTDZX

Will FTDZX outperform in future?

Get our overall rating based on a fundamental assessment of the pillars below.

  • Process Pillar

    The Process Pillar is our assessment of how sensible, clearly defined, and repeatable FTDZX’s performance objective and investment process is for both security selection and portfolio construction.

  • People Pillar

    The People Pillar is our evaluation of the FTDZX management team’s experience and ability. We find that high-quality management teams deliver superior performance relative to their benchmarks and/or peers.

  • Parent Pillar

    The Parent Pillar is our rating of FTDZX’s parent organization’s priorities and whether they’re in line with investors’ interests.

Experienced team but not yet a standout.

Director Katie Rushkewicz Reichart

Katie Rushkewicz Reichart

Director

Summary

Franklin Biotechnology Discovery has an experienced team at the helm, but it needs to distinguish itself.

by Katie Rushkewicz Reichart
Rated on Published on

Unlock our full analysis with Morningstar Investor

Portfolio Holdings FTDZX

More FTDZX Holdings
  • Current Portfolio Date
  • Equity Holdings —
  • Bond Holdings —
  • Other Holdings —
  • % Assets in Top 10 Holdings 38.9
Top 10 Holdings
% Portfolio Weight
Market Value USD
Sector

Amgen Inc

6.77 64.3 Mil
Healthcare

Regeneron Pharmaceuticals Inc

6.30 59.9 Mil
Healthcare

Vertex Pharmaceuticals Inc

5.24 49.8 Mil
Healthcare

Ascendis Pharma A/S ADR

4.05 38.5 Mil
Healthcare

Franklin IFT Money Market

3.69 35.1 Mil
Cash and Equivalents

Gilead Sciences Inc

3.12 29.6 Mil
Healthcare

Biogen Inc

2.94 27.9 Mil
Healthcare

AstraZeneca PLC ADR

2.83 26.8 Mil
Healthcare

Intra-Cellular Therapies Inc

2.59 24.6 Mil
Healthcare

Jazz Pharmaceuticals PLC

2.58 24.5 Mil
Healthcare